Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 703, pseudogene (RN7SL703P) is a human pseudogene related to the 7SL RNA component of the signal recognition particle. Unlike functional 7SL RNA genes, RN7SL703P is a non-functional, truncated sequence resulting from the reverse transcription of 7SL RNA back into genomic DNA, often exhibiting deletions at the 5' or 3' ends or both[2][3][5]. The majority of 7SL-like sequences in the human genome are pseudogenes and not transcriptionally active; they do not encode functional RNA or protein products, nor do they participate in biological processes or disease mechanisms[1][2][3][5][6]. Pseudogenes such as RN7SL703P are not considered therapeutic targets, nor are they relevant to drug interactions, mechanisms of action, patient biomarkers, or safety concerns. Key contextual notes: - RN7SL703P is strictly annotated as a pseudogene, with no evidence of functional RNA or protein product, no associated cellular or disease role, and no drug interactions[1][2][3][6]. - The functional 7SL RNA is a crucial component of the signal recognition particle, which mediates protein translocation, but pseudogenes like RN7SL703P do not contribute to this activity[2][4][5]. - There is nothing to suggest misspelling; however, the entry is not a therapeutic target and lacks relevant biological, pharmacological, or clinical information[1][2][6]. If you seek a therapeutic target, use a functional 7SL RNA gene (e.g., RN7SL1, RN7SL2) rather than RN7SL703P[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 703, pseudogene (RN7SL703P).